3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
7
Thoracic
3
Other hematologic neoplasm
3
Head & Neck
3
Gastrointestinal
3
Lymphoid
2
CNS
2
Breast
2
NET
1
Endocrine
1
Dermatologic
1
Conditions
Brain Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Temozolomide
31
Magnetic Resonance Spectroscopy
31
Specimen Handling
18
Radiation
13
Radiotherapy
12
Biopsy
11
Bevacizumab
11
Nivolumab
9
X-Rays
7
Radiosurgery
7
Nuclear Medicine Department, Hospital
7
Carboplatin
7
Lomustine
6
Cyclophosphamide
6
Vincristine
5
Phantoms, Imaging
5
Cisplatin
5
ulixertinib
4
trametinib
4
pembrolizumab
4
erdafitinib
4
binimetinib
4
abemaciclib
4
Irinotecan
4
Ipilimumab
4
Immunoglobulin G
4
Etoposide
4
Disulfides
4
Aminolevulinic Acid
4
AZD 6244
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Watchful Waiting
×
CNS
×
30 days
×
Clear all
NCT05375617
2026-06-02
EPICkids
Columbia University
Recruiting
1,400 enrolled
NCT06974370
2026-05-26
ACTION-Brain
University of Vermont Medical Center
Phase 2
Recruiting
45 enrolled